Stealth BioTherapeutics is looking to put its tumultuous path behind it with a new name. That new name is mighty—literally, as the biopharma is now Mighty Therapeutics, reflecting its recent change ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

You won’t hear this from either critics or fans of President Trump’s tariffs, but there’s a manufacturing revival going on. The reason you haven’t heard is that it doesn’t easily fit either political ...

Turtle Beach has unveiled its newest flagship wireless headset for PC and consoles, the Stealth Pro 2. Mixing a refreshed design with high-quality audio and multiplatform functionality, the Stealth ...

It may look like a laptop we all know, but MSI's latest revision of its slim gaming and power-user Stealth line could be its most compelling yet. I have been a technology journalist for 30-plus years ...

Ronald is a Contributor at DualShockers with more than a decade of experience covering video games. He began writing about games in 2013 through public forums, reviews, news, and opinion pieces, ...

The MSI Stealth A16 AI+ is a unicorn laptop that does it all: it's powerful, packed with features, great for multimedia, great for gaming, and great for all kinds of work. It's even portable, too. If ...

After a tumultuous journey filled with delays and rejection, the FDA has approved Stealth BioTherapeutics’ treatment for the ultrarare disease Barth syndrome, marking the peptide as the first therapy ...

A second B-21 Raider bomber has flown for the first time in California, the Air Force announced Thursday, a milestone officials say will accelerate testing of America’s first new long-range bomber in ...

Stealth in video games has become something that many games use in a certain capacity. But for these games coming out next year, you might want to use them more often than not. Before you say anything ...

The rapidly approaching September decision date may reflect a renewed urgency from the agency, which has thrice rejected Stealth BioTherapeutics' elamipretide. (Ali Shahgholi/iStock/Getty Images Plus) ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...